Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Chronic Pain Clinical Trial

Official title:

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05968664
• Other study ID #: H-49405
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2024
• Est. completion date: January 2028

Study information

• Verified date: August 2023
• Source: Baylor College of Medicine
• Contact: Ashwin Viswanathan, MD
• Phone: 7132138181
• Email: ashwinv[@]bcm.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieved by current standard of care SCS.

Description:

The researchers will conduct a traditional exploratory feasibility study using an investigational device to compare the clinical outcomes using time varying pulse (TVP) waveforms against time-invariant pulse (TIP) waveforms using both paresthesia and paresthesia-free SCS therapies. The therapy longevity of TVPs and TIPS will also be evaluated by tracking therapy efficacy through a long-term follow-up phase, using multiple pain assessments and at-home digital data collection.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 43
• Est. completion date: January 2028
• Est. primary completion date: January 2028
• Accepts healthy volunteers: No
• Gender: All
• Age group: 22 Years and older

Eligibility

Inclusion Criteria:

• Ability to provide informed consent

• Age = 22

• Chronic pain of the trunk and/or limbs for at least 6 months

• Baseline average daily overall pain score of >6 on the Numerical Rating Scale collected with a 7-day pain diary related to pain of the trunk and/or limbs

• Failed >3 medically supervised treatments (i.e. pain medications, physical therapy, facet joint/medial branch nerve blocks, acupuncture), and treatment with >2 classes of medications

• Stable pain-related medication regimen 4 weeks prior to the trial. No new pain medication will be added during the study period

• No back surgery within 6 months prior to Screening

• Consumed an average total daily morphine equivalent of =200 mg during the 30 days prior to Screening.

• Baseline Oswestry Disability Index score =40 and =80

• Eligible candidate for SCS from a psychological and psychiatric standpoint as determined within 180 days prior to Baseline Visit, per site's routine screening process

• Able to independently read and complete all questionnaires and assessments provided in English

• Female candidates of child-bearing potential agree to use contraception during the study period

• Deemed to be a good candidate for spinal cord stimulation by the PI, and a board certified pain management physician

• Willing to cooperate with study requirements

Exclusion Criteria:

• Patient exhibits catastrophization based on physician evaluation (e.g., average overall daily pain intensity of 10 on a 0-10 numerical rating scale, every day during the 7 days prior to Screening, based on patient recall)

• Pain originating from peripheral vascular disease

• Active treatment for cancer in past 6 months

• Involved in disability litigation

• High surgical risk including documented history of allergic response to titanium or silicone, current systemic infection, or local infection in close proximity to anticipated surgical field

• Body mass index = 45 at Screening

• Terminal illness with anticipated survival < 12 months

• Participant is immunocompromised

• Significant cognitive impairment at Screening that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study

• Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study

• Previous spinal cord stimulation trial/implant or is already implanted with an active implantable device(s) (e.g. drug pump, implantable pulse generator)

• A pregnant female or a female of childbearing potential planning to get pregnant during the course of the study

• Plan to receive any massage or manipulation directly over the leads or by the anticipated location of the IPG or treatments that involve sudden jerking motions of the torso at any

• Existing medical condition that is likely to require the use of diathermy

• Any injury or medical/psychological condition that might be significantly exacerbated by the implant surgery or the presence of an implantable stimulator or otherwise compromise subject safety

• Unable to operate the study devices including wrist-worn biosensor and mobile app

• Documented history of substance abuse or dependency in the 6 months prior to baseline

Related Conditions & MeSH terms

• Chronic Pain
• Neuralgia
• Neuropathic Pain
• Pain, Neuropathic

Intervention

Device:
• Spinal Cord Stimulator
Spinal Cord Stimulator modified to deliver Time Variant Pulse (TVP) stimulation.
• Spinal Cord Stimulator
Spinal Cord Stimulator to deliver standard of care Time Invariant Pulse (TIP) stimulation.

Locations

Country	Name	City	State
United States	Baylor College of Medicine	Houston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
Ashwin Viswanathan	Boston Scientific Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Patient responder rate	The primary endpoint for this trial will be a comparison of the percentage of patients achieving at least a 50% reduction in pain during the TIP stimulation block with the percentage of patients achieving at least a 50% reduction in pain during either TVP stimulation block.	Patient responder rate will be measured from the baseline and during three experimental stimulation periods which are 8±3 weeks each.